Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-31

FDA Approved: MESALAMINE — Original Application (KLM Laboratories Private Limited)

View source ↗

Summary

FDA approved KLM Laboratories Private Limited's mesalamine generic under an Original Application (ANDA 220016) for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)